Reshma Kewalramani serves as Executive at VERTEX PHARMACEUTICALS INC / MA, where they oversee executive responsibilities. Since joining the company, Reshma Kewalramani has executed 113 insider transactions totaling $58.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 24, 2026 involved selling 4,981 shares valued at $2.4M.
Reshma Kewalramani currently holds 138,278 shares of VERTEX PHARMACEUTICALS INC / MA (VRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Reshma Kewalramani has been a net seller of VRTX stock. They have purchased $5.9M and sold $53.1M worth of shares.
Reshma Kewalramani's most recent insider trade was on Feb 24, 2026, when they sold 4,981 shares at $485.11 per share.
Get notified when new Form 4 filings are submitted
| $389.95 |
| Discretionary |
| Aug 6, 2025 | VRTX | $1.7M | Purchase | 4,290 | $389.08 | Discretionary |
| Jul 30, 2024 | VRTX | $7.7M | Sale | 15,202 | $505.00 | Planned |
| Jul 22, 2024 | VRTX | $7.6M | Sale | 15,202 | $497.00 | Planned |
| Jun 12, 2024 | DNA | $0 | Option Exercise | 105,263 | $N/A | Discretionary |
| May 24, 2024 | VRTX | $293.5K | Option Exercise | 1,565 | $187.53 | Planned |
| May 24, 2024 | VRTX | $715.2K | Sale | 1,565 | $457.00 | Planned |
| May 20, 2024 | VRTX | $6.8M | Sale | 15,202 | $447.00 | Planned |
| Feb 23, 2024 | VRTX | $4.1M | Payment | 9,386 | $431.79 | Discretionary |
| Feb 20, 2024 | VRTX | $3.0M | Payment | 7,019 | $420.58 | Discretionary |
| Feb 16, 2024 | VRTX | $4.0M | Payment | 9,359 | $424.01 | Discretionary |
| Feb 9, 2024 | VRTX | $3.5M | Payment | 8,255 | $422.74 | Discretionary |
| Feb 7, 2024 | VRTX | $0 | Award | 20,327 | $N/A | Discretionary |
| Feb 6, 2024 | VRTX | $0 | Award | 14,516 | $N/A | Discretionary |
| Feb 6, 2024 | VRTX | $0 | Award | 26,972 | $N/A | Discretionary |
| Dec 15, 2023 | VRTX | $475.7K | Option Exercise | 3,058 | $155.57 | Planned |
| Dec 15, 2023 | VRTX | $7.0M | Sale | 17,135 | $407.00 | Planned |
| Dec 15, 2023 | VRTX | $2.6M | Option Exercise | 14,077 | $187.53 | Planned |
| Dec 13, 2023 | VRTX | $2.0M | Sale | 5,098 | $397.00 | Planned |
| Nov 13, 2023 | VRTX | $1.9M | Sale | 5,097 | $377.00 | Planned |
| Jul 17, 2023 | VRTX | $2.8M | Sale | 7,828 | $355.00 | Planned |
| Apr 27, 2023 | VRTX | $566.2K | Sale | 1,668 | $339.43 | Planned |
| Apr 27, 2023 | VRTX | $545.6K | Sale | 1,611 | $338.69 | Planned |
| Apr 27, 2023 | VRTX | $12.9K | Sale | 38 | $340.19 | Planned |
| Feb 24, 2023 | VRTX | $2.7M | Payment | 9,386 | $289.12 | Discretionary |
| Feb 17, 2023 | VRTX | $2.7M | Payment | 9,359 | $292.85 | Discretionary |
| Feb 13, 2023 | VRTX | $1.8M | Payment | 5,990 | $298.26 | Discretionary |
| Feb 10, 2023 | VRTX | $992.5K | Payment | 3,372 | $294.33 | Discretionary |
| Feb 1, 2023 | VRTX | $0 | Award | 12,388 | $N/A | Discretionary |